Home/ Supplements/ Calcium/ Calcium Citrate 250 mg

Calcium Citrate 250 mg

product on market Tablet or Pill Bronson Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Calcium Citrate 250 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
180
Servings
Other Combinations
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
250 mg (19% DV)
L-Glutamic Acid HCl
50 mg

Other Ingredients

Stearic Acid Microcrystalline Cellulose Croscarmellose Sodium Magnesium Stearate Silicon Dioxide purified Water Hydroxypropyl Methylcellulose Polyethylene Glycol Titanium Dioxide
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement for adults, take 1 tablet one to four times daily, preferably with a meal, or as directed by a healthcare professional.

Warnings & Precautions

Warning: If you are pregnant, nursing or taking any medications, consult your doctor before use.

Discontinue use if any adverse reactions occur.

Do not use if seal under cap is broken or missing.

Keep out of reach of children.

Formulation Notes

Supports healthy bones Bioavailable

Citrate form Calcium formulas

Additional Information

Since 1960 Nutrition+

Store at room temperature.

Discover the Bronson Difference To reorder: www.bronsonvitamins.com 1-800-235-3200

Metadata

Product Details

UPC / SKU7 16563 12601 8
DSLD Entry Date2021-12-18
Product TypeOther Combinations
FormTablet or Pill
BrandBronson
DSLD ID257400
Data Updated2026-04-11
Research

Research Evidence

511
Research Sources
57
Avg Quality
266
Meta Analysis
95
Systematic Review
76
Rct
49
Clinical Trial
12
Guideline
4
Regulatory Source
2
Cochrane Review
2
Other
2
Narrative Review
1
Openfda Safety
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A First-line drugs for hypertension
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Beta-blockers for hypertension
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Calcium →
Compare

Similar Products

View all Calcium products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.